{{Rsnum
|rsid=8126
|Gene=TNFAIP2
|Chromosome=14
|position=103137232
|Orientation=plus
|GMAF=0.3737
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=TNFAIP2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 0.0
| HCB | 13.9 | 47.4 | 38.7
| JPT | 11.5 | 49.6 | 38.9
| YRI | 3.6 | 17.9 | 78.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 13.9 | 47.4 | 38.7
| CHD | 12.8 | 50.5 | 36.7
| GIH | 23.8 | 33.7 | 42.6
| LWK | 10.9 | 14.5 | 74.5
| MEX | 0.0 | 0.0 | 0.0
| MKK | 6.4 | 23.1 | 70.5
| TSI | 7.9 | 26.7 | 65.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=21934093
|Title=A Functional Variant at the miR-184 Binding Site in TNFAIP2 and Risk of Squamous Cell Carcinoma of the Head and Neck
|OA=1
}}

{{PMID Auto
|PMID=23724109
|Title=The miR-184 Binding-Site rs8126 T&gt;C Polymorphism in TNFAIP2 Is Associated with Risk of Gastric Cancer
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}